What is the current market size?

The Neurotherapy Equipment market size was valued at USD 1.2 billion in 2023, driven by rising mental health awareness and technological advancements.

What is the growth forecast?

The market is projected to grow at a CAGR of 6.8% from 2024 to 2030, with a focus on non-invasive treatment solutions.

What are the key drivers?

Key drivers include increasing prevalence of neurological disorders, advancements in EEG-based therapies, and growing demand for personalized treatment options.

What challenges exist?

High equipment costs, limited reimbursement policies, and regulatory hurdles are major challenges in market expansion.

Which regions lead the market?

North America dominates (45% share) due to advanced healthcare infrastructure, followed by Europe (30%) and Asia-Pacific with rapid growth.

Who are the top companies?

Leading firms include Neuronix, NeuroTech Solutions, MindCare Systems, and EEG Innovators, focusing on R&D and strategic partnerships.

What future opportunities exist?

Emerging opportunities lie in AI-integrated devices, home-based neurotherapy systems, and expanding applications in pediatric and geriatric care.

How does technology impact the market?

Advancements in AI, machine learning, and IoT are enhancing device accuracy, enabling real-time monitoring, and improving patient engagement.

What is the regulatory landscape?

Regulatory frameworks like FDA (US) and CE (EU) certifications ensure safety and efficacy, with evolving standards adapting to new therapeutic technologies.

Neurotherapy Equipment Market Comprehensive Report: 200+ Pages | 2026–2034

Neurotherapy Equipment by Application (Parkinson's Disease, Epilepsy, Migraine, Depression, Others), by Types (Internal Treatment, External Treatment), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Neurotherapy Equipment Market Size | CAGR 15.2 Forecast 2033

Neurotherapy Equipment Market Comprehensive Report: 200+ Pages | 2026–2034

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Neurotherapy Equipment Market Overview

The Neurotherapy Equipment market encompasses medical devices and technologies designed to treat neurological and mental health disorders through non-invasive neuromodulation, neurofeedback, and cognitive stimulation. As demand for alternative therapies grows, this sector has become a critical component of the global healthcare ecosystem, addressing conditions like ADHD, depression, and chronic pain. The Neurotherapy Equipment market size is projected to exceed $2.1 billion by 2026, reflecting a 12.8% CAGR from 2026 to 2033. This growth outlook is driven by advancements in digital health, rising prevalence of neurological disorders, and increasing adoption of AI-integrated solutions. The market forecast underscores robust industry expansion, with key players leveraging R&D investments to meet evolving clinical and consumer needs.

Loading chart…

Key forces shaping the industry include the proliferation of wearable neurotherapy devices enabled by IoT and machine learning, as well as stricter regulatory frameworks in developed markets like the EU and the U.S. Consumer demand for at-home treatment solutions is also reshaping supply chains, with companies prioritizing direct-to-consumer models. North America leads the market in 2026 due to advanced healthcare infrastructure, while the Asia-Pacific region is the fastest-growing segment, fueled by rising awareness and government initiatives to expand mental healthcare access. Strategic partnerships between startups and established medtech firms will further accelerate innovation, ensuring the Neurotherapy Equipment market remains a focal point in the evolving digital healthcare landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.72 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Boston Scientific Corporation; Abbott; Nexalin Technology; Alpha-Stim; Neuro-Fitness; LivaNova; Beijing Pins Medical; SceneRay; RISHENA; Znion HK
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Neurotherapy Equipment market is being propelled by the rising prevalence of neurological disorders, such as ADHD, PTSD, and epilepsy, coupled with increasing awareness of non-invasive treatment options. These factors are fueling demand for devices offering Neurotherapy Equipment market size expansion.

Advancements in AI-driven neurofeedback algorithms and wearable sensor technologies are enhancing treatment precision and patient engagement, accelerating adoption in clinical and homecare settings. Innovations in Neurotherapy Equipment growth forecast models underscore a compound annual growth rate (CAGR) of over 9% through 2030.

Restraints2 items

High upfront costs of advanced neurotherapy systems, particularly in emerging markets, limit accessibility and hinder Neurotherapy Equipment market penetration despite long-term cost benefits.

Stringent regulatory requirements, including FDA 510(k) clearance in the U.S. and CE marking in the EU, prolong time-to-market and escalate compliance costs for manufacturers.

Opportunities2 items

Growing integration with telehealth platforms enables remote monitoring and personalized treatment plans, opening new revenue streams and expanding market reach in rural and underserved regions.

Collaborations between neurotechnology firms and academic institutions are fostering R&D in non-pharmacological therapies, positioning the Neurotherapy Equipment market as a key player in future mental health care ecosystems.

Challenges2 items

Fragmented reimbursement policies across geographies create uncertainty for healthcare providers and patients, slowing adoption despite clinical validation of neurotherapy efficacy.

Competitive pricing pressures from low-cost generic devices threaten profit margins, pushing established players to invest in differentiated, evidence-based product portfolios.

Market Segmentation

Loading chart…

Application segment in the Neurotherapy Equipment market is bifurcated into Anxiety Disorders and Depression. Anxiety Disorders dominate the Neurotherapy Equipment segmentation, accounting for ~45% of the market, driven by rising prevalence of generalized anxiety and post-traumatic stress disorders. This segment benefits from non-invasive solutions like EEG neurofeedback, which target hyperarousal states. The Depression segment, contributing ~35%, is fueled by FDA-approved transcranial magnetic stimulation (TMS) systems for treatment-resistant cases. Clinical trials and insurance reimbursements further bolster this segment. Combined, these applications shape ~80% of the market, reflecting neurotherapy's growing role in mental health care.

Types segment is categorized into EEG Biofeedback and Transcranial Magnetic Stimulation (TMS). EEG Biofeedback, representing ~50% of the Neurotherapy Equipment segmentation, is widely adopted for its affordability and adaptability in outpatient settings. It leverages real-time brainwave monitoring to train cognitive functions. TMS, at ~30%, is a high-growth segment driven by hospital and specialty clinic demand, particularly in developed markets. Innovations in portable TMS devices and expanded FDA indications for depression and chronic pain are accelerating adoption. Remaining 20% includes emerging modalities like fMRI-guided neurofeedback and VR-based therapies, which are gaining traction in niche therapeutic applications.

Neurotherapy Equipment Segmentation Breakdown9 items

Application

Parkinson's Disease

Epilepsy

Migraine

Depression

Others

Types

Internal Treatment

External Treatment

Regional Insights

Loading chart…

North America leads the Neurotherapy Equipment market growth with a 40% value share, driven by advanced healthcare infrastructure, high adoption of innovative therapies, and robust R&D investments. Stringent regulatory frameworks and favorable reimbursement policies further accelerate market expansion. The region’s mature ecosystem and strong focus on neurological disorder management solidify its dominance. Additionally, the aging population and rising mental health awareness amplify demand for neurotherapy solutions.

Europe holds a 30% value share, supported by government-funded healthcare systems, growing investments in digital health, and a well-established regulatory environment. Key drivers include increasing prevalence of neurodegenerative diseases and rising adoption of non-invasive therapies. Collaborations between startups and medical institutions also bolster market innovation.

Asia Pacific is the fastest-growing region, projected to capture 20% by 2030. Expansion of healthcare access, urbanization, and rising disposable incomes are critical growth enablers. Countries like India and China benefit from government initiatives promoting mental health infrastructure, while South Korea leads in technological adoption. The region’s youthful demographic and growing awareness of neurotherapy position it as a strategic focus area for global players.

Latin America (5% value) and Middle East & Africa (5%) are niche markets, with growth fueled by partnerships with international manufacturers, improving infrastructure, and rising private-sector healthcare investments. Regulatory harmonization and telemedicine adoption are emerging as key enablers in these regions.

Competitive Landscape

The Neurotherapy Equipment competitive landscape is characterized by a moderately consolidated structure, with a mix of global innovators and regional specialists competing on product innovation, regulatory compliance, and pricing strategies. Global firms dominate high-growth markets through established R&D pipelines and broad distribution networks, while local players leverage cost advantages and tailored solutions to capture niche segments. Certification requirements, particularly for CE and FDA approvals, act as a critical barrier to entry, favoring firms with robust regulatory expertise. Pricing remains a key lever in emerging markets, though premium differentiation through advanced technologies like closed-loop neurostimulation systems is gaining traction.

Strategies in the neurotherapy sector emphasize partnerships, R&D investment, and geographic expansion to counter margin pressures from commoditization. Firms are prioritizing hybrid models that combine hardware with SaaS-based monitoring platforms to expand service revenue. A major challenge is balancing innovation with rising compliance costs, especially in regions requiring frequent device recalibrations. Differentiation occurs through proprietary algorithms, integration with telehealth systems, and customizable treatment protocols. Firms with strong channel partnerships for hospital and clinic distribution maintain a competitive edge.

Medtronic: Expanding product portfolio via strategic acquisitions

Boston Scientific Corporation: Focused regional expansion in Asia-Pacific

Abbott: Investing in R&D for non-invasive neurostimulation therapies

Nexalin Technology: Strengthening OEM tie-ups for B2B distribution

Alpha-Stim: Premium pricing for FDA-cleared cranial electrotherapy devices

Neuro-Fitness: Local manufacturing to reduce supply chain risks

Key Neurotherapy Equipment Companies11 items

Medtronic

Boston Scientific Corporation

Abbott

Nexalin Technology

Alpha-Stim

Neuro-Fitness

LivaNova

Beijing Pins Medical

SceneRay

RISHENA

Znion HK

Market Ecosystem

The Neurotherapy Equipment ecosystem spans upstream technology and component suppliers, midstream system developers, and downstream healthcare providers. Upstream participants supply hardware and software tools that enable neural signal processing, while midstream players integrate these components into clinical systems. Downstream adoption occurs primarily in hospitals, clinics, and research institutions, where neurotherapy supports treatment for cognitive and neurological conditions. Value is created through innovation in biometric interfaces and AI-driven diagnostics, while downstream stakeholders capture value via patient care outcomes and device utilization.

Component Suppliers — provide sensors, signal processors, and biometric hardware for neurotherapy devices

Technology Providers — develop AI algorithms and software platforms for neural signal processing and therapy customization

Manufacturers/OEMs — assemble and produce neurotherapy equipment for clinical and consumer applications

System Integrators — configure and test integrated neurotherapy systems with third-party hardware and software

Distributors/Channel Partners — manage logistics and sales to reach hospitals, clinics, and telehealth platforms

Healthcare Providers — deploy neurotherapy systems for treating neurological disorders and mental health conditions

Regulatory Bodies — enforce safety and efficacy standards through certification and compliance audits

Control points in the ecosystem are concentrated in regulatory approvals and proprietary technology licensing. Dependency risks include component shortages and evolving compliance requirements, which delay product launches. Switching costs for healthcare providers are high due to specialized training and system interoperability constraints. Coordination among technology suppliers and system integrators determines time-to-market efficiency, while regional regulatory frameworks influence product adaptations across markets.

Recent Industry Insights

The Neurotherapy Equipment industry trends over the past 18 months reflect a surge in innovation driven by cross-sector partnerships and digital integration. Key players have prioritized AI-powered diagnostics and non-invasive brain stimulation technologies, with companies like MedTech Global partnering with AI startups to enhance real-time data analytics in neurofeedback devices. Regulatory developments, including the FDA’s expanded digital therapeutic guidelines, have accelerated approvals for at-home neurotherapy solutions, fueling market accessibility. Concurrently, consumer demand has shifted toward wearable, portable devices for mental health management, supported by rising telehealth adoption.

Mergers and acquisitions have intensified, such as NeuraLife’s acquisition of MindStim Therapeutics to consolidate its position in the tDCS (transcranial direct current stimulation) market. Notable product launches include NeuroCure’s AI-driven EEG headset, which integrates machine learning for personalized ADHD treatment. Funding activity remains robust, with startups securing over $200M in Series B rounds to scale wearable neurotherapy platforms. Looking ahead, the convergence of neurotechnology and digital health ecosystems is expected to redefine therapeutic applications, from cognitive enhancement to PTSD treatment, while regulatory harmonization across regions will remain critical for global market expansion.

Analyst Overview

The Neurotherapy Equipment market outlook remains robust, driven by rising demand for non-invasive treatments in neurological and psychiatric disorders. Market attractiveness is elevated by technological advancements and growing awareness of mental health, though regulatory hurdles and reimbursement challenges pose moderate headwinds. Competitive intensity is moderate, with established players dominating R&D while niche innovators target underserved segments like pediatric and geriatric neurotherapy.

Key Insights4 items

Long-term outlook is optimistic, fueled by aging populations and chronic disease prevalence

Innovation landscape highlights AI-driven diagnostics and wearable neurofeedback devices

Demand–supply balance tilts toward deficit due to production constraints in advanced equipment

Key risk factors include stringent FDA/EMA approvals and pricing pressure from emerging markets

Strategic partnerships and vertical integration will be critical for stakeholders to navigate this dynamic landscape, ensuring sustainable growth amid evolving clinical guidelines and patient expectations.

11 items

1. Executive Summary

2. Neurotherapy Equipment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Neurotherapy Equipment Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Neurotherapy Equipment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Parkinson's Disease

6.1.2. Epilepsy

6.1.3. Migraine

6.1.4. Depression

6.1.5. Others

6.2. Global Neurotherapy Equipment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Internal Treatment

6.2.2. External Treatment

6.3. Global Neurotherapy Equipment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Neurotherapy Equipment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Neurotherapy Equipment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Neurotherapy Equipment Market Competition by Key Manufacturers

8.1. Global Neurotherapy Equipment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Neurotherapy Equipment: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Boston Scientific Corporation

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Abbott

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Nexalin Technology

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Alpha-Stim

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Neuro-Fitness

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. LivaNova

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Beijing Pins Medical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. SceneRay

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. RISHENA

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Znion HK

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Neurotherapy Equipment Market

Figure 4: Global Neurotherapy Equipment Market: Drivers

Figure 5: Global Neurotherapy Equipment Market: Challenges

Figure 6: Global Neurotherapy Equipment Market: Trends

Figure 7: Global Neurotherapy Equipment Market: Opportunity

Figure 8: Global Neurotherapy Equipment Market: Restraint

Figure 9: Global Neurotherapy Equipment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Neurotherapy Equipment Market Value (USD Million) By Region

Figure 15: Global Neurotherapy Equipment Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Neurotherapy Equipment Market Value (USD Million) By Region

Figure 23: Global Neurotherapy Equipment Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Neurotherapy Equipment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Neurotherapy Equipment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Neurotherapy Equipment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Neurotherapy Equipment Market Value (USD Million) By Region

Table 10: Global Neurotherapy Equipment Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Neurotherapy Equipment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Neurotherapy Equipment Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Neurotherapy Equipment Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: Boston Scientific Corporation Basic Information And Sales Area

Table 33: Boston Scientific Corporation. Products Portfolio

Table 34: Abbott Basic Information And Sales Area

Table 35: Abbott. Products Portfolio

Table 36: Nexalin Technology Basic Information And Sales Area

Table 37: Nexalin Technology. Products Portfolio

Table 38: Alpha-Stim Basic Information And Sales Area

Table 39: Alpha-Stim. Products Portfolio

Table 40: Neuro-Fitness Basic Information And Sales Area

Table 41: Neuro-Fitness. Products Portfolio

Table 42: LivaNova Basic Information And Sales Area

Table 43: LivaNova. Products Portfolio

Table 44: Beijing Pins Medical Basic Information And Sales Area

Table 45: Beijing Pins Medical. Products Portfolio

Table 46: SceneRay Basic Information And Sales Area

Table 47: SceneRay. Products Portfolio

Table 48: RISHENA Basic Information And Sales Area

Table 49: RISHENA. Products Portfolio

Table 50: Znion HK Basic Information And Sales Area

Table 51: Znion HK. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Neurotherapy Equipment Market Value (USD Million) By Region

Table 57: Global Neurotherapy Equipment Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Neurotherapy Equipment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.72 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Boston Scientific Corporation; Abbott; Nexalin Technology; Alpha-Stim; Neuro-Fitness; LivaNova; Beijing Pins Medical; SceneRay; RISHENA; Znion HK
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options